Victory Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-13,416
| Closed | -$10.8K | – | 2488 |
|
2025
Q1 | $10.8K | Sell |
13,416
-262
| -2% | -$211 | ﹤0.01% | 2450 |
|
2024
Q4 | $18.9K | Sell |
13,678
-354
| -3% | -$489 | ﹤0.01% | 2449 |
|
2024
Q3 | $14.6K | Sell |
14,032
-112
| -0.8% | -$116 | ﹤0.01% | 2460 |
|
2024
Q2 | $24.5K | Buy |
14,144
+165
| +1% | +$285 | ﹤0.01% | 2414 |
|
2024
Q1 | $33.4K | Sell |
13,979
-327
| -2% | -$782 | ﹤0.01% | 2410 |
|
2023
Q4 | $47.6K | Buy |
14,306
+3,206
| +29% | +$10.7K | ﹤0.01% | 2439 |
|
2023
Q3 | $41.5K | Sell |
11,100
-1,040
| -9% | -$3.89K | ﹤0.01% | 2399 |
|
2023
Q2 | $51.8K | Sell |
12,140
-187
| -2% | -$798 | ﹤0.01% | 2382 |
|
2023
Q1 | $84.3K | Sell |
12,327
-2,782
| -18% | -$19K | ﹤0.01% | 2382 |
|
2022
Q4 | $120K | Sell |
15,109
-3
| -0% | -$24 | ﹤0.01% | 2337 |
|
2022
Q3 | $145K | Buy |
15,112
+1,333
| +10% | +$12.8K | ﹤0.01% | 2412 |
|
2022
Q2 | $100K | Buy |
13,779
+443
| +3% | +$3.22K | ﹤0.01% | 2461 |
|
2022
Q1 | $121K | Buy |
+13,336
| New | +$121K | ﹤0.01% | 2491 |
|
2021
Q4 | – | Sell |
-97,320
| Closed | -$1.56M | – | 2784 |
|
2021
Q3 | $1.56M | Sell |
97,320
-30,358
| -24% | -$488K | ﹤0.01% | 1677 |
|
2021
Q2 | $1.77M | Sell |
127,678
-4,837
| -4% | -$66.9K | ﹤0.01% | 1668 |
|
2021
Q1 | $1.94M | Buy |
132,515
+114,668
| +643% | +$1.68M | ﹤0.01% | 1658 |
|
2020
Q4 | $310K | Buy |
17,847
+3,737
| +26% | +$64.9K | ﹤0.01% | 2274 |
|
2020
Q3 | $259K | Buy |
+14,110
| New | +$259K | ﹤0.01% | 2214 |
|
2020
Q2 | – | Sell |
-20,308
| Closed | -$330K | – | 2653 |
|
2020
Q1 | $330K | Buy |
20,308
+8,904
| +78% | +$145K | ﹤0.01% | 2218 |
|
2019
Q4 | $205K | Buy |
11,404
+1,541
| +16% | +$27.7K | ﹤0.01% | 2307 |
|
2019
Q3 | $200K | Buy |
+9,863
| New | +$200K | ﹤0.01% | 2220 |
|